Delivery Order SPE2DB22D2211-SPE2DB24FPDK9
Award Date
8/14/24
Potential Completion Date
8/15/24
Potential Value
$28K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division worth $10,786.94 for the supply of STELARA 90 MG/ML syringes. This is a firm fixed-price, full and open competition contract with no set-aside designation, with a period of performance through June 28, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to...
This federal contract award, issued by the Defense Logistics Agency (DLA), was made to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The $16,607.52 fixed-price delivery order is for the supply of STELARA 90 MG/ML syringes, with a completion date of May 14, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, to provide a...
The U.S. Defense Logistics Agency (DLA) awarded a $43,007.62 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML SYRINGEML. This contract has an ultimate completion date of October 11, 2024 and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $14,779.58 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division for the supply of STELARA 90 MG/ML syringes. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide STELARA 90 MG/ML SYRINGE medical supplies. The contract has a total potential value of $21,211.14 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor and the contract does not have a set-aside designation. This delivery order is part of a larger indefinite delivery contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a delivery order contract valued at $30,858.83 for the supply of STELARA 90 MG/ML syringes. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen...
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corporation for the supply of STELARA 90 MG/ML SYRINGE. The $29,832.99 firm fixed-price contract has a period of performance through September 4, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical supplies without a set-aside designation. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between AmerisourceBergen...
The U.S. Defense Logistics Agency (DLA) awarded a $13,431.40 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of Stelara 90 mg/ml syringes. This contract has a period of performance through June 10, 2024 and is not designated as a set-aside. Amerisourcebergen is a major pharmaceutical distribution company that holds a $999,999,999.00 indefinite delivery contract (IDC) with DLA Troop Support Medical to provide a comprehensive range...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Stelara 45 mg/0.5 ml syringes. The firm-fixed-price contract has a ceiling value of $12,719.25 and a period of performance through April 19, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 2025, which serves as the...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply STELARA 90 MG/ML SYRINGEML. The $41,389.84 firm-fixed-price contract has a completion date of September 30, 2024. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical, valued up to $999,999,999, and the Department of Justice Federal Bureau of Investigation, valued up to $750,000, to provide a...